Latest Breaking News On - Adamj townsend - Page 1 : comparemela.com

Needham & Company LLC Reiterates Buy Rating for Apellis Pharmaceuticals (NASDAQ:APLS)

Needham & Company LLC Reiterates Buy Rating for Apellis Pharmaceuticals (NASDAQ:APLS)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Adamj townsendDavido watsonJennison associatesApellis pharmaceuticals stock downApellis pharmaceuticalsApellis pharmaceuticals incNeedham companyPricet rowe associates incNews ratings for apellis pharmaceuticals dailyAnalyst recommendations for apellis pharmaceuticalsPolar capital holdings plcInstitutional investors weigh in on apellis pharmaceuticalsNorges bankJefferies financial groupFree reportFinancial group

Apellis Pharmaceuticals (NASDAQ:APLS) Announces Quarterly Earnings Results, Meets Estimates

Apellis Pharmaceuticals (NASDAQ:APLS) Announces Quarterly Earnings Results, Meets Estimates
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Adamj townsendRaymond jamesPascal deschateletsApellis pharmaceuticals trading downSecurities exchange commissionApellis pharmaceuticalsApellis pharmaceuticals incNews ratings for apellis pharmaceuticals dailyJefferies financial groupEarnings history for apellis pharmaceuticalsGet free reportPharmaceuticals trading downExchange commissionApellis pharmaceuticals daily

Apellis Pharmaceuticals (NASDAQ:APLS) Earns Buy Rating from Needham & Company LLC

Apellis Pharmaceuticals (NASDAQ:APLS) Earns Buy Rating from Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesZurcher kantonalbank zurich cantonalbankNur nicholsonAdamj townsendApellis pharmaceuticals incFirst horizon advisors incApellis pharmaceuticals company profileApellis pharmaceuticals stock performanceAnalyst recommendations for apellis pharmaceuticalsGoldman sachs groupApellis pharmaceuticalsAssetmark incJpmorgan chase coNeedham companyYork mellon corpSecurities exchange commission

Apellis Pharmaceuticals (NASDAQ:APLS) Issues Earnings Results, Meets Expectations

Apellis Pharmaceuticals (NASDAQ:APLS) Issues Earnings Results, Meets Expectations
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

A sinclair dunlopRobertw bairdAdamj townsendApellis pharmaceuticalsApellis pharmaceuticals stock performanceApellis pharmaceuticals incSecurities exchange commissionInsider activity at apellis pharmaceuticalsJpmorgan chase coNews ratings for apellis pharmaceuticals dailyGoldman sachs groupEarnings history for apellis pharmaceuticalsGet free reportExchange commissionApellis pharmaceuticals daily

Needham & Company LLC Reiterates Buy Rating for Apellis Pharmaceuticals (NASDAQ:APLS)

Needham & Company LLC Reiterates Buy Rating for Apellis Pharmaceuticals (NASDAQ:APLS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesDavido watsonAdamj townsendNeedham companySecurities exchange commissionNews ratings for apellis pharmaceuticals dailyJefferies financial groupApellis pharmaceuticals price performanceFirst horizon advisors incApellis pharmaceuticals incHedge funds weigh in on apellis pharmaceuticalsFinancial wealth managmentAnalyst recommendations for apellis pharmaceuticalsApellis pharmaceuticalsGoldman sachs groupGet free report